PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO A DEBENTURE HOLDER.   QUEBEC, January 22, 2021 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical...

PRESS RELEASE For immediate release Devonian Health Group Announces Closing of a Private Placement and the Grant of Stock Options.   Not for distribution to United States newswire services or for dissemination in the United States QUEBEC, December 30, 2020 –...

PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO DEBENTURE HOLDERS.   QUEBEC City, October 9, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage...

PRESS RELEASE For immediate release DEVONIAN ANNOUNCES CORRECTION TO PRESS RELEASE ISSUED JULY 28, 2020.   QUEBEC, July 30, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation,...

PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO A DEBENTURE HOLDER AND STOCK OPTION GRANTS.   QUEBEC, July 28, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a...

PRESS RELEASE For immediate release Devonian Health Group Announces Notice of Allowance for a US Patent Application Covering use of Thykamine™ for the treatment of Ulcerative Colitis.   QUEBEC, June 15, 2020 – Devonian Health Group Inc. (“Devonian” or the...

PRESS RELEASE For immediate release Devonian Health Group announces completion of Enrollment in its Phase 2 Clinical Trial of Thykamine™ for the Treatment of mild-to-moderate Atopic Dermatitis in adult population.   Last-patient-last-visit took place on June 3rd,...

PRESS RELEASE For immediate release Devonian Health Group Announces Change to its Board of Directors.   QUEBEC, June 5, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused...

PRESS RELEASE For immediate release Devonian Health Group Announces an Exclusive Strategic Alliance with CannTx Life Sciences for the development of Cannabinoid-based Pharmaceutical Drugs.   Combination of Devonian’s Botanical Drug expertise with CannTx Life...

PRESS RELEASE For immediate release Devonian Health Group Announces the nomination of Dr André P. Boulet to the American Botanical Drug Association.   Dr Boulet to represent Canada within the organization QUEBEC, May 21st, 2020 – Devonian Health Group Inc....